Author:
Åkeson P.,Jonsson E.,Haugen I.,Holtås S.
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Clinical Neurology,Radiology Nuclear Medicine and imaging
Reference16 articles.
1. Brasch RC, Bennett HF (1988) Considerations in the choice of contrast media for MR imaging. Radiology 166:897–899
2. Parizel PM, Degryse HR, Gheuens J et al (1989) Gadolinium-DOTA enhanced MR imaging of intracranial lesions. J Comput Assist Tomogr 13: 378–383
3. Almén T (1989) Relations between chemical structure, animal toxicity and clinical adverse effects of contrast media. In: Enge I, Edgren J (eds) Patient safety and adverse events in contrast medium examinations. Elsevier, Amsterdam, pp 25–45
4. Van Wagoner M, Rocklage SM (1991) Gadodiamide injection, a nonionic MRI enhancement agent: overview of development. In: Rinck PA, Muller RN (eds) New development in contrast agent research. European Magnetic Resonance Forum, Blonay, pp 49–55
5. Van Wagoner M, O'Toole M, Quay SC (1990) Nonionic magnetic resonance imaging contrast agents: clinical trial experience of safety, tolerance and efficacy of Gadodiamide injection. Invest Radiol 25 [Suppl 1]: 39–41
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献